GLYCOMIMETICS INC

Company

CRESCENT BIOPHARMA, INC.

Filed

November 4, 2024

Accession Number

0000902664-24-006210

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →